Artificial intelligence for animal-testing-free research
Using artificial intelligence (AI) to improve research on human cells in a test tube or petri dish (in vitro): this is how new medicines against health conditions like liver diseases could be developed. Animal testing would then become obsolete.
Joint research
Research organisation TNO, the Dutch Society for the Replacement of Animal Testing (Stichting Proefdiervrij) and pharmaceutical company Galapagos are investing in joint research that connects a wealth of available information. To this end, they are using artificial intelligence. In doing so, the parties believe that they can learn a lot about how medicines work in human bodies. As a result, they expect to have to resort to animal testing less often in the future. The research is being followed up on by the Mechpath project at the Bio Science Park in Leiden.